SUVEN PHARMACEUTICALS
|
SUVEN PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
Equity - Issued | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹17 Cr | ₹1.97 Cr | - | - | - |
Total Reserves | ₹1,654 Cr | ₹2,023 Cr | ₹1,710 Cr | ₹1,502 Cr | ₹1,155 Cr |
Securities Premium | ₹110 Cr | ₹110 Cr | ₹110 Cr | ₹110 Cr | ₹110 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹1,384 Cr | ₹1,765 Cr | ₹1,465 Cr | ₹1,273 Cr | ₹936 Cr |
General Reserves | ₹124 Cr | ₹124 Cr | ₹124 Cr | ₹109 Cr | ₹94 Cr |
Other Reserves | ₹36 Cr | ₹24 Cr | ₹11 Cr | ₹10 Cr | ₹15 Cr |
Reserve excluding Revaluation Reserve | ₹1,654 Cr | ₹2,023 Cr | ₹1,710 Cr | ₹1,502 Cr | ₹1,155 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹1,697 Cr | ₹2,051 Cr | ₹1,735 Cr | ₹1,527 Cr | ₹1,181 Cr |
Minority Interest | ₹144 Cr | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹6.24 Cr | - | ₹4.56 Cr | ₹28 Cr | ₹36 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹7.89 Cr | - | ₹4.56 Cr | ₹28 Cr | ₹36 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-1.65 Cr | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹90 Cr | ₹65 Cr | ₹58 Cr | ₹54 Cr | ₹31 Cr |
Deferred Tax Assets | ₹97 Cr | ₹11 Cr | ₹2.21 Cr | ₹1.48 Cr | ₹2.47 Cr |
Deferred Tax Liability | ₹188 Cr | ₹76 Cr | ₹60 Cr | ₹56 Cr | ₹33 Cr |
Other Long Term Liabilities | ₹728 Cr | ₹21 Cr | ₹0.70 Cr | ₹0.46 Cr | ₹0.74 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.26 Cr | - | ₹8.30 Cr | ₹8.90 Cr | ₹6.65 Cr |
Total Non-Current Liabilities | ₹825 Cr | ₹86 Cr | ₹72 Cr | ₹92 Cr | ₹74 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹80 Cr | ₹42 Cr | ₹70 Cr | ₹106 Cr | ₹83 Cr |
Sundry Creditors | ₹80 Cr | ₹42 Cr | ₹70 Cr | ₹106 Cr | ₹83 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹196 Cr | ₹21 Cr | ₹20 Cr | ₹30 Cr | ₹29 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.62 Cr | ₹0.69 Cr | ₹0.81 Cr | ₹3.80 Cr | ₹0.01 Cr |
Interest Accrued But Not Due | ₹0.24 Cr | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹194 Cr | ₹21 Cr | ₹19 Cr | ₹26 Cr | ₹29 Cr |
Short Term Borrowings | ₹70 Cr | ₹39 Cr | ₹65 Cr | ₹67 Cr | ₹106 Cr |
Secured ST Loans repayable on Demands | ₹70 Cr | ₹39 Cr | ₹65 Cr | ₹67 Cr | ₹64 Cr |
Working Capital Loans- Sec | ₹70 Cr | ₹39 Cr | ₹45 Cr | ₹47 Cr | ₹44 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-70 Cr | ₹-39 Cr | ₹-45 Cr | ₹-47 Cr | ₹-2.74 Cr |
Short Term Provisions | ₹19 Cr | ₹15 Cr | ₹149 Cr | ₹145 Cr | ₹104 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹1.10 Cr | - | ₹145 Cr | ₹141 Cr | ₹102 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹18 Cr | ₹15 Cr | ₹3.95 Cr | ₹4.08 Cr | ₹2.61 Cr |
Total Current Liabilities | ₹365 Cr | ₹117 Cr | ₹303 Cr | ₹348 Cr | ₹322 Cr |
Total Liabilities | ₹3,031 Cr | ₹2,254 Cr | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr |
ASSETS | |||||
Gross Block | ₹2,046 Cr | ₹929 Cr | ₹876 Cr | ₹694 Cr | ₹570 Cr |
Less: Accumulated Depreciation | ₹332 Cr | ₹260 Cr | ₹212 Cr | ₹160 Cr | ₹128 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1,713 Cr | ₹670 Cr | ₹663 Cr | ₹534 Cr | ₹441 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹255 Cr | ₹179 Cr | ₹165 Cr | ₹30 Cr | ₹96 Cr |
Non Current Investments | ₹145 Cr | ₹131 Cr | ₹117 Cr | ₹117 Cr | ₹361 Cr |
Long Term Investment | ₹145 Cr | ₹131 Cr | ₹117 Cr | ₹117 Cr | ₹361 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹145 Cr | ₹131 Cr | ₹117 Cr | ₹117 Cr | ₹361 Cr |
Long Term Loans & Advances | ₹24 Cr | ₹22 Cr | ₹9.19 Cr | ₹13 Cr | ₹11 Cr |
Other Non Current Assets | ₹4.58 Cr | - | - | ₹7.30 Cr | ₹0.16 Cr |
Total Non-Current Assets | ₹2,143 Cr | ₹1,001 Cr | ₹955 Cr | ₹702 Cr | ₹910 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹192 Cr | ₹774 Cr | ₹419 Cr | ₹481 Cr | ₹181 Cr |
Quoted | ₹192 Cr | ₹774 Cr | ₹378 Cr | ₹451 Cr | - |
Unquoted | ₹0.18 Cr | - | ₹41 Cr | ₹30 Cr | ₹181 Cr |
Inventories | ₹167 Cr | ₹231 Cr | ₹313 Cr | ₹283 Cr | ₹201 Cr |
Raw Materials | ₹61 Cr | ₹46 Cr | ₹77 Cr | ₹72 Cr | ₹51 Cr |
Work-in Progress | ₹49 Cr | ₹101 Cr | ₹113 Cr | ₹132 Cr | ₹98 Cr |
Finished Goods | ₹37 Cr | ₹63 Cr | ₹99 Cr | ₹60 Cr | ₹33 Cr |
Packing Materials | ₹3.76 Cr | ₹4.40 Cr | ₹4.04 Cr | ₹2.55 Cr | ₹3.00 Cr |
Stores  and Spare | ₹16 Cr | ₹17 Cr | ₹19 Cr | ₹17 Cr | ₹15 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹284 Cr | ₹134 Cr | ₹111 Cr | ₹236 Cr | ₹102 Cr |
Debtors more than Six months | ₹5.58 Cr | - | - | - | - |
Debtors Others | ₹282 Cr | ₹134 Cr | ₹111 Cr | ₹236 Cr | ₹102 Cr |
Cash and Bank | ₹89 Cr | ₹51 Cr | ₹68 Cr | ₹47 Cr | ₹9.65 Cr |
Cash in hand | ₹0.04 Cr | ₹0.07 Cr | ₹0.05 Cr | ₹0.09 Cr | ₹0.09 Cr |
Balances at Bank | ₹89 Cr | ₹50 Cr | ₹68 Cr | ₹47 Cr | ₹9.56 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹15 Cr | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹12 Cr |
Interest accrued on Investments | ₹1.37 Cr | ₹0.43 Cr | ₹0.28 Cr | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹10 Cr | ₹4.92 Cr | ₹8.63 Cr | ₹6.40 Cr | ₹4.40 Cr |
Other current_assets | ₹3.45 Cr | ₹6.55 Cr | ₹2.55 Cr | ₹4.47 Cr | ₹7.44 Cr |
Short Term Loans and Advances | ₹107 Cr | ₹52 Cr | ₹233 Cr | ₹206 Cr | ₹161 Cr |
Advances recoverable in cash or in kind | ₹23 Cr | ₹1.97 Cr | ₹25 Cr | ₹24 Cr | ₹13 Cr |
Advance income tax and TDS | - | - | ₹144 Cr | ₹137 Cr | ₹104 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹84 Cr | ₹50 Cr | ₹64 Cr | ₹45 Cr | ₹44 Cr |
Total Current Assets | ₹853 Cr | ₹1,253 Cr | ₹1,155 Cr | ₹1,265 Cr | ₹667 Cr |
Net Current Assets (Including Current Investments) | ₹488 Cr | ₹1,136 Cr | ₹852 Cr | ₹918 Cr | ₹345 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹3,031 Cr | ₹2,254 Cr | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr |
Contingent Liabilities | ₹19 Cr | ₹18 Cr | ₹6.07 Cr | ₹6.07 Cr | ₹6.07 Cr |
Total Debt | ₹78 Cr | ₹39 Cr | ₹69 Cr | ₹96 Cr | ₹141 Cr |
Book Value | - | 80.48 | 68.16 | 59.99 | 46.39 |
Adjusted Book Value | 65.97 | 80.47 | 68.16 | 59.99 | 46.39 |
Compare Balance Sheet of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹37,869.7 Cr | 12.7% | 9.4% | -12.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 1% | -0.2% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -2.7% | -2.2% | 17.6% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -1.7% | 4.1% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | 1% | 1.3% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 2.5% | 7.7% | -6.7% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 12.7% |
9.4% |
-12.1% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses